137 related articles for article (PubMed ID: 28760904)
1. Molecular Characterization of Fluoroquinolone-Resistant Moraxella catarrhalis Variants Generated
Yamada K; Saito R; Muto S; Kashiwa M; Tamamori Y; Fujisaki S
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760904
[No Abstract] [Full Text] [Related]
2. Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Nakai H; Sato T; Uno T; Furukawa E; Kawamura M; Takahashi H; Watanabe A; Fujimura S
J Infect Chemother; 2018 Feb; 24(2):83-87. PubMed ID: 29290527
[TBL] [Abstract][Full Text] [Related]
3. Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV.
Nakase K; Sakuma Y; Nakaminami H; Noguchi N
Anaerobe; 2016 Dec; 42():166-171. PubMed ID: 27793740
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
Puig C; Tirado-Vélez JM; Calatayud L; Tubau F; Garmendia J; Ardanuy C; Marti S; de la Campa AG; Liñares J
Antimicrob Agents Chemother; 2015 Jan; 59(1):461-6. PubMed ID: 25385097
[TBL] [Abstract][Full Text] [Related]
5. Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
Ehrmann E; Jolivet-Gougeon A; Bonnaure-Mallet M; Fosse T
J Antimicrob Chemother; 2017 Aug; 72(8):2208-2212. PubMed ID: 28453633
[TBL] [Abstract][Full Text] [Related]
6. DNA gyrase and topoisomerase IV mutations in an in vitro fluoroquinolone-resistant Coxiella burnetii strain.
Vranakis I; Sandalakis V; Chochlakis D; Tselentis Y; Psaroulaki A
Microb Drug Resist; 2010 Jun; 16(2):111-7. PubMed ID: 20438350
[TBL] [Abstract][Full Text] [Related]
7. In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.
Drago L; Nicola L; Mattina R; De Vecchi E
BMC Microbiol; 2010 Apr; 10():119. PubMed ID: 20409341
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Type II Topoisomerase Mutations to Fluoroquinolone Resistance in Enterococcus faecium from Japanese Clinical Setting.
Urushibara N; Suzaki K; Kawaguchiya M; Aung MS; Shinagawa M; Takahashi S; Kobayashi N
Microb Drug Resist; 2018; 24(1):1-7. PubMed ID: 28504916
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.
Hsu SF; Lin YT; Chen TL; Siu LK; Hsueh PR; Huang ST; Fung CP
J Microbiol Immunol Infect; 2012 Apr; 45(2):134-40. PubMed ID: 22154675
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1.
Talukder KA; Khajanchi BK; Islam MA; Islam Z; Dutta DK; Rahman M; Watanabe H; Nair GB; Sack DA
Curr Microbiol; 2006 Feb; 52(2):108-11. PubMed ID: 16450072
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
13. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
Zhou Y; Yu L; Li J; Zhang L; Tong Y; Kan B
Int J Antimicrob Agents; 2013 Jul; 42(1):72-5. PubMed ID: 23643392
[TBL] [Abstract][Full Text] [Related]
15. Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.
Rafii F; Park M; Novak JS
Antimicrob Agents Chemother; 2005 Feb; 49(2):488-92. PubMed ID: 15673722
[TBL] [Abstract][Full Text] [Related]
16. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
Jones RN; Fritsche TR; Sader HS; Stilwell MG
Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
18. High-Level Macrolide-Resistant Moraxella catarrhalis and Development of an Allele-Specific PCR Assay for Detection of 23S rRNA Gene A2330T Mutation: A Three-Year Study at a Chinese Tertiary Hospital.
Liu Y; Xu H; Xu Z; Kudinha T; Fan X; Xiao M; Kong F; Sun H; Xu Y
Microb Drug Resist; 2015 Oct; 21(5):507-11. PubMed ID: 25923017
[TBL] [Abstract][Full Text] [Related]
19. Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.
Piccinelli G; Gargiulo F; Corbellini S; Ravizzola G; Bonfanti C; Caruso A; De Francesco MA
Antimicrob Agents Chemother; 2015 Apr; 59(4):2466-9. PubMed ID: 25666148
[TBL] [Abstract][Full Text] [Related]
20. [MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones].
Malakhova MV; Vereshchagin VA; Il'ina EN; Govorun VM; Filimonova OIu; Grudinina SA; Sidorenko SV
Antibiot Khimioter; 2007; 52(1-2):10-7. PubMed ID: 18461803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
